$CPRT

This Copart Analyst Turns Bullish; Here Are Top 2 Upgrades For Friday - Illumina (NASDAQ:ILMN), Copart (N

Barrington Research upgraded Copart (CPRT) to Outperform with a $40 target, while Freedom Broker upgraded IES Holdings (IESC) to Buy with a $440 target. CPRT closed at $30.75 and IESC at $319.52 on Thursday.

Original reporting
Published Sep 11, 2026, 5:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 12:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$CPRT
Bullish
medium confidence
Mentioned
$CPRT · $IESC · $ILMN
Relevance
5/10
AlphAI data visualization · based on benzinga.com
Decision brief

The 30-second read

$CPRTBullishMed
01

Why it matters

Both upgrades suggest near-term bullish pressure on the stocks.

02

Market read

Two analyst upgrades may generate modest buying interest in the mentioned stocks.

03

What to watch

Potential macro slowdown could dampen demand for used vehicles.

Relevance 5/10Novelty 5/10Timing: today

Background

Analyst rating changes are a common catalyst for short-term price moves.

Company-level read

Ticker impact

$CPRTBullishMedium confidence
Context

Barrington Research upgraded Copart (CPRT) to Outperform with a $40 price target.

Expected impact

Modest price gain in the next few days.

Evidence & confidence

Upgrade and new target may attract buyers, but limited scale.

$IESCBullishMedium confidence
Context

Freedom Broker upgraded IES Holdings (IESC) to Buy with a $440 price target.

Expected impact

Small to moderate upside if market reacts.

Evidence & confidence

Upgrade signals improved outlook; target suggests upside.

Market effects

Auto auction sector may see modest uplift from analyst upgrades.

U.S. market participants could adjust positions in related transport stocks.

Limited; primarily U.S. equity focus.

Counterpoint

Upgrades may be premature if underlying earnings miss expectations.

Key entities

  • Barrington Research

    Provided upgrade for Copart.

  • Freedom Broker

    Provided upgrade for IES Holdings.

Related articles

$MRNAMed

Moderna’s Rally May Have Run Out of Steam. Here’s What to Watch Next

Moderna (MRNA) shares fell 20% after leaked trial data for its melanoma vaccine, despite analysts calling results 'strong.' The drop may signal the end of its 700% year-to-date rally. Merck (MRK), partnering on the vaccine, saw minimal impact. Analysts expect Merck to report strong earnings. BioNTech (BNTX) and Illumina (ILMN) are also mentioned.

$CPRTMedAI 9/10

Copart Completes $1.9B Buyout of Buffalo's ACV Auctions

Copart completed its $1.9B acquisition of ACV Auctions, paying $10.50 per share. ACV is now a subsidiary of Copart and will operate independently. ACV reported $760M revenue in 2025, up 19%, but a net loss of $66M. Copart aims to expand its vehicle remarketing business through the deal, expecting earnings neutrality in the first year and accretion from 2028.

$CPRTHighAI 9/10

COPART INC (CPRT): Completion of Acquisition or Disposition of Assets

COPART INC (CPRT) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 Copart Completes Acquisition of ACV DALLAS – October 16, 2026 – Copart, Inc. (NASDAQ: CPRT) (“Copart”), a global leader in online vehicle auctions, today announced the successful completion of its acquisition of ACV Auctions Inc. (NYSE: ACVA) (“ACV”). “We are pleased